Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-beta

Eur J Immunol. 1991 Jul;21(7):1635-9. doi: 10.1002/eji.1830210708.

Abstract

Transforming growth factor-beta 1 (TGF-beta 1) mediates many immunosuppressive effects on immune cells and can inhibit the production of tumor necrosis factor and interleukin 1 (IL 1). However, TGF-beta 1 can stimulate the production of IL 6 and platelet-derived growth factor, indicating that TGF-beta 1 initiates complex effects on the production of cytokines. In this report we show that treatment of peripheral blood monocytes with TGF-beta 1 leads to the induction of a recently described IL 1 receptor antagonist protein (IRAP). The effect of TGF-beta 1 was both dose and time dependent. TGF-beta 1 induced de novo synthesis of IRAP, as Northern blotting experiments indicated a rapid and transient induction of the mRNA encoding IRAP. The induction of IRAP suggests a potential mechanism by which some of the inhibitory effects of TGF-beta 1 are mediated.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • Humans
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1 / biosynthesis
  • Protein Biosynthesis*
  • Proteins / genetics
  • RNA, Messenger / biosynthesis
  • Recombinant Proteins / biosynthesis
  • Sialoglycoproteins*
  • Transforming Growth Factor beta / pharmacology*

Substances

  • IL1RN protein, human
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1
  • Proteins
  • RNA, Messenger
  • Recombinant Proteins
  • Sialoglycoproteins
  • Transforming Growth Factor beta